List of Contents

Dermatology Excimer Laser Market Size, Share and Trends 2025 to 2034

The global dermatology excimer laser market size is accounted at USD 711.67 million in 2025 and is forecasted to hit around USD 1,725.35 million by 2034, representing a CAGR of 10.34% from 2025 to 2034. The North America market size was estimated at USD 251.54 million in 2024 and is expanding at a CAGR of 10.56% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : 21 Apr 2025
  • Report Code : 5959
  • Category : Healthcare

Dermatology Excimer Laser Market Size and Forecast 2025 to 2034

The global dermatology excimer laser market size was estimated at USD 644.98 million in 2024 and is predicted to increase from USD 711.67 million in 2025 to approximately USD 1,725.35 million by 2034, expanding at a CAGR of 10.34% from 2025 to 2034. The growth of the dermatology excimer laser market is driven by the rising prevalence of skin diseases and high demand for cosmetic procedures.

Dermatology Excimer Laser Market Size 2025 to 2034

Dermatology Excimer Laser Market Key Takeaways

  • By region, North America dominated the market with the largest share in 2024.
  • By region, Asia Pacific is projected to witness the fastest growth in the coming years.
  • By product, the trolley-mounted excimer laser segment dominated the market in 2024.
  • By product, the handheld excimer laser segment is expected to expand at the highest CAGR between 2025 and 2034.
  • By application, the psoriasis segment held the dominant share of the market in 2024.
  • By application, the vitiligo segment is anticipated to grow at the fastest rate in the upcoming period.
  • By end-use, the dermatology clinics segment led the market in 2024.
  • By end-use, the plastic surgery centers segment is anticipated to witness the fastest growth during the forecast period.

AI Integration in the Dermatology Excimer Lasers

Integrating artificial intelligence (AI) algorithms in dermatology excimer lasers significantly enhances treatment outcomes. AI-driven excimer lasers identify skin conditions and recognize skin type, aiding in precise diagnosis and assisting dermatologists in formulating personalized treatment plans tailored to individual patients. AI-laser technology transforms skin resurfacing using micro-columns of energy to penetrate deeply into the skin. AI-driven lasers analyze skin issues and adjust energy levels accordingly to deliver personalized treatments more safely and precisely. This precision lowers human errors and increases the outcomes of treatment and patients. AI-driven laser enhances diagnostic accuracy, enabling personalized treatment plans and improving the efficiency of cosmetic procedures.

U.S. Dermatology Excimer Laser Market Size and Growth 2025 to 2034

The U.S. dermatology excimer laser market size was evaluated at USD 176.08 million in 2024 and is projected to be worth around USD 480.47 million by 2034, growing at a CAGR of 10.56% from 2025 to 2034.

U.S. Dermatology Excimer Laser Market Size 2025 to 2034

North America dominated the dermatology excimer laser market by capturing the largest share in 2024. The region’s dominance is mainly attributed to the rise in incidences of skin diseases. Facial post-inflammatory hyperpigmentation, melasma, and solar dermatitis are the most often occurring skin diseases in North America.

  • The region’s robust healthcare sector and the availability of advanced surgical technologies further bolstered the market growth in the region.

The U.S. is a major contributor to the North American dermatology excimer laser market. The country is home to some of the leading medical device manufacturing companies, leading to rapid innovations in dermatology excimer lasers. The rising number of dermatology clinics and demand for cosmetic procedures further contribute to market growth.

Asia Pacific is anticipated to witness the fastest growth during the forecast period. There is a high burden of skin diseases, including atopic dermatitis, alopecia areata, acne, decubitus ulcers, contact dermatitis, psoriasis, seborrheic dermatitis, and pruritus, in Asian countries, particularly low-income countries. The rising awareness among people about the timely treatment of skin diseases also supports regional market growth. In China, the prevalence of skin diseases is high, affecting the overall health and well-being of people. The Chinese government is investing heavily to boost the development of novel surgical devices, contributing to the growth of the dermatology excimer laser market in the Asia Pacific.

India is expected to have a stronghold on the market. With continuous climate change, the number of cases of skin infection, irritation, and sunburn is increasing. This, in turn, boosts the demand for skin treatments. The rising healthcare spending further supports market growth. In addition, the Indian government programs like Ayushman Bharat aim to improve healthcare accessibility and provide free access to health insurance coverage for low-income groups, which contributes to market expansion.

Dermatology Excimer Laser Market Share, By Region, 2024 (%)

Europe is observed to grow at a significant rate in the foreseeable future. The growth of the dermatology excimer laser market in Europe can be attributed to the increasing prevalence of skin diseases, such as skin fungal infection, acne, atopic dermatitis, alopecia, and psoriasis. The strong presence of excimer laser manufacturing companies such as Fotona d.o.o., EKA R&D Corp., Asclepion Laser Technologies GmbH, and Quanta System S.p.A. further drives the market. In addition, the rising demand for minimally invasive cosmetic procedures contributes to regional market growth.

Market Overview

The dermatology excimer laser market is growing rapidly due to the rising prevalence of skin disorders, such as acne and eczema, leading to a burden on healthcare systems worldwide. Thus, the high burden of subcutaneous and skin diseases increases the demand for dermatology excimer laser treatment. Excimer laser therapy uses a laser beam that emits ultraviolet (UV) light to target and treat specific areas of the skin. This therapy is a highly effective option that delivers targeted phototherapy for efficient and precise skin clearance. The rising awareness among people about skin health contributes to market growth. Excimer lasers increase efficacy in treating skin conditions like atopic dermatitis, psoriasis, vitiligo, allergic rhinitis, alopecia areata, and folliculitis. Moreover, the growing awareness about the benefits of minimally invasive procedures significantly boosts the growth of the market.

Dermatology Excimer Laser Market Growth Factors

  • The increasing awareness among consumers about the benefits of excimer laser treatment is driving the growth of the market.
  • The rising demand for cosmetic procedures further boosts the growth of the market. As the demand for cosmetic procedures increases, so does the need for excimer lasers in dermatology clinics.
  • The rising preference for ablative laser stacking therapy for skin rejuvenation and the treatment of scars, severe sun damage, wrinkles, and acne further drives market growth.
  • Technological advancements in medical devices, including dermatology excimer lasers, contribute to market growth.
  • The growing desire for glowing skin among people is expected to boost the growth of the market in the coming years.

Market Scope

Report Coverage Details
Market Size by 2034 USD 1,725.35 Billion
Market Size in 2025 USD 711.67 Billion
Market Size in 2024 USD 644.98 Billion
Market Growth Rate from 2025 to 2034 CAGR of 10.34%
Dominated Region North America
Fastest Growing Market Asia Pacific
Base Year 2024
Forecast Period 2025 to 2034
Segments Covered Product, Application, End Use, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Market Dynamics

Drivers

Rising Prevalence of Refractory Pediatric Dermatological Conditions

The rising incidence of refractory pediatric skin disorders like atopic dermatitis (AD) and psoriasis is a major factor driving the growth of the dermatology excimer laser market. AD, in particular, is a chronic, inflammatory skin disease characterized by complex pathophysiology involving genetic predisposition, epidermal barrier dysfunction, immune dysregulation, and environmental triggers. As conventional treatments fail to achieve sustained relief in moderate to severe cases, particularly among children, there is a growing demand for targeted, non-invasive alternatives such as excimer laser therapy. This rising need for effective and precision treatments is propelling healthcare providers and dermatology centers to adopt excimer lasers, driving the growth of the market.

Restraint

High Costs and Potential Side Effects

Excimer laser therapy is expensive, making it inaccessible to many patients. Excimer lasers are costlier and require continuous maintenance and repair, creating challenges for healthcare facilities and dermatology clinics, especially those operating with budget constraints. Handling these laser devices requires specialized training, which can increase overhead expenses, particularly in smaller or resource-limited settings. In addition, excimer laser treatments can cause skin irritations and scars, depending on time of application. This may create hesitation among patients undergoing excimer laser therapy, limiting the growth of the market.

Opportunity

Expansion of Teledermatology

The rising integration of teledermatology in healthcare practices creates immense opportunities in the dermatology excimer laser market. By enabling the remote diagnosis and management of skin conditions through high-resolution imaging and digital communication platforms, teledermatology increases access to specialist care, particularly in rural and underserved regions. This shift not only enhances diagnostic accuracy and care continuity but also drives demand for decentralized treatment solutions, including portable and clinic-friendly excimer laser systems. This trend supports the wider deployment of excimer laser devices in teledermatology-enabled hospitals, fueling the growth of the market.

Product Insights

The trolley-mounted excimer laser segment led the dermatology excimer laser market with the largest share in 2024. This is mainly due to the increased preference of these lasers in dermatology clinics for their enhanced accuracy and ability to treat various skin diseases. These lasers improve the delivery and precision of UVB energy to targeted tissue. The rise in the preference for precision results and faster therapeutic benefits further bolstered the segment. These lasers deliver UVB light in an adequate amount, reducing the total number of treatments required and the risk of side effects and skin cancer.

The handheld excimer laser segment is expected to expand at the highest CAGR during the forecast period. These lasers are widely preferred for their portability and user-friendly features. Handheld systems are majorly applied for intense monochromatic UVB therapy and in treating skin diseases like vitiligo and psoriasis. Dermatologists can easily move this handheld device over the surface of the patient’s skin, enhancing comfort and flexibility. These lasers are suitable for both hospital and home settings.

Application Insights

The psoriasis segment held the largest share of the dermatology excimer laser market in 2024. This is mainly due to the heightened demand for targeted and minimally invasive therapies. The excimer laser is efficient for inducing apoptosis in T lymphocytes and keratinocytes, which are the two main cells involved in the pathogenesis of psoriasis. Huge doses of excimer laser therapy also lower the number of pathogenic memory T cells that penetrate the lesional dermis and epidermis in psoriatic lesions, reducing inflammation in the clearance of psoriatic lesions. Excimer lasers are highly effective in the treatment of psoriasis due to their ability to target specific areas, reducing damage to healthy skin tissues.

The vitiligo segment is anticipated to grow at the fastest rate in the upcoming period as excimer laser therapy, along with topical immunosuppressive treatment, is recommended in vitiligo treatment. The excimer laser is a workable management therapy for vitiligo and may yield results greater than other therapies. Excimer lasers allow for precise targeting of vitiligo patches, enhancing treatment outcomes.

End-use Insights

The dermatology clinics segment dominated the dermatology excimer market in 2024. This is mainly due to the increased patient pool in dermatology clinics. These clinics are often equipped with advanced surgical devices and skilled staff, encouraging patients to receive care from these settings. The rise in the number of cosmetic surgeries performed in these settings further bolstered the segmental growth. These settings also offer personalized care, attracting more patients.

The plastic surgery centers segment is anticipated to witness the fastest growth during the forecast period. The precision and versatility of excimer lasers make them ideal for achieving optimal results with minimal risks and reduced downtime. Excimer laser treatments have revolutionized the area of plastic surgery. These lasers effectively address a broad range of cosmetic challenges, including scar reduction, skin rejuvenation, and hair removal in the plastic surgery center. The rising demand for cosmetic surgeries further contributes to the growth of the segment.

Dermatology Excimer Laser Market Companies

Dermatology Excimer Laser Market Companies
  • Ra Medical Systems, Inc.
  • Shenzhen GSD Tech Co., Ltd.
  • Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.)
  • Strata Skin Sciences, Inc.
  • The Daavlin Company
  • Fotona d.o.o.
  • Beijing Sincoheren S&T Development Co., Ltd
  • Lumenis, Ltd.
  • Hologic, Inc.
  • DEKA Research & Development Corp.

Recent Developments

  • In July 2024, STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announced the approval of its XTRAC Momentum 1.0 device by the Ministry of Health, Labor, and Welfare of Japan. XTRAC excimer laser technology allows for the precise delivery of targeted UVB light therapy to specific treatment areas of the skin.
  • In January 2024, Bausch + Lomb Corporation announced that the U.S. Food and Drug Administration has approved the TENEO Excimer Laser Platform for laser-assisted in situ keratomileusis (LASIK) vision correction surgery for myopia and myopic astigmatism.

Segments Covered in the Report

By Product

  • Tabletop Excimer Lasers
  • Hand-Held Excimer Lasers
  • Trolley Mounted Excimer Lasers

By Application

  • Psoriasis
  • Vitiligo
  • Atopic Dermatitis
  • Allergic Rhinitis
  • Alopecia Areata
  • Others

By End-use

  • Hospitals
  • Dermatology Clinics
  • Plastic Surgery Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

The global dermatology excimer laser market size is expected to grow from USD 644.98 million in 2024 to USD 1,725.35 million by 2034.

The dermatology excimer laser market is anticipated to grow at a CAGR of 10.34% between 2025 and 2034.

The major players operating in the dermatology excimer laser market are Ra Medical Systems, Inc. Shenzhen GSD Tech Co., Ltd., Alma Lasers (Shanghai Fosun Pharmaceutical Group Co., Ltd.), Strata Skin Sciences, Inc., The Daavlin Company, Fotona d.o.o., Beijing Sincoheren S&T Development Co., Ltd, Lumenis, Ltd., Hologic, Inc., DEKA Research & Development Corp., and Others.

The driving factors of the dermatology excimer laser market are the growth of the dermatology excimer laser market is driven by the rising prevalence of skin diseases and high demand for cosmetic procedures.

North America region will lead the global dermatology excimer laser market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Rohan Patil is one such expert who is helping shape the future of healthcare market insights with his deep industry knowledge and forward-thinking approach. Rohan holds a BSc. in Biotechnology and an MBA in Marketing, a combination that allows him to blend scientific understanding with strategic business acumen. With over 5 years of experience in the market research industry, Rohan

Learn more about Rohan Patil

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports